


【博瑞医药:上半年净利润同比下降83.85%】财联社8月28日电,博瑞医药(688166.SH)公告称,2025年上半年营业收入为5.37亿元,同比下降18.28%;归属于上市公司股东的净利润为1717.32万元,同比下降83.85%。
“特别声明:以上作品内容(包括在内的视频、图片或音频)为凤凰网旗下自媒体平台“大风号”用户上传并发布,本平台仅提供信息存储空间服务。
Notice: The content above (including the videos, pictures and audios if any) is uploaded and posted by the user of Dafeng Hao, which is a social media platform and merely provides information storage space services.”